DURHAM, NC--(Marketwired - Jun 26, 2013) - Mi-Co, the Mobile Information Corporation and a Microsoft Gold ISV partner, announced today that it has been named a recipient of the 2013 Microsoft Life Sciences Innovation Awards.
The awards, which were announced at the Drug Information Association's (DIA) 49th annual meeting in Boston, honor companies that are using Microsoft solutions to realize business and information technology benefits. The 2013 winners are revolutionizing medicine by bringing therapeutic breakthroughs to the market faster, to fight serious ailments, improve healthcare and enhance patients' quality of life.
"Today, the life sciences industry is tasked with not only bringing new therapies to the market faster, but doing so at a lower cost," said Andrea McGonigle, Managing Director, Life Sciences, Microsoft Corp. "The winners of this year's Microsoft Life Sciences Innovation Awards all faced that challenge head on, demonstrating sustainable impacts to the life sciences industry through the use of innovative technology."
Mi-Co Customer, Infectious Disease Clinical Research Program (IDCRP), used Mi-Forms mobile-forms software and Windows-Tablets, to almost eliminate all paper case report forms for a multi-site clinical trial with offline capture requirements, and reduced queries by 100x, produced a 50% data-entry savings and increased coordinator satisfaction considerably. Mi-Forms is a Microsoft .NET-based platform, with SQL Server driving the Mi-Forms Server product, which is responsible for version control, workflow and user authentication. Read more about this success story here.
According to Gautham Pandiyan, VP of Sales & Marketing, "Mi-Co is very pleased to receive this award from Microsoft, as it recognizes Mi-Co's leading role in bringing Tablet solutions to the life sciences market, and its experience over 13 years of implementing Tablet solutions. We look forward to replicating the success our customers have seen, with other organizations looking to adopt Tablets to boost efficiency, productivity and accuracy."
Award submissions were received from pharmaceutical, biotechnology, clinical resource, and medical device companies from across the world, which are applying Microsoft technology to create therapeutic innovations. Winners, chosen by an esteemed panel of industry experts, were selected based on how their innovation represents a breakthrough from the industry, how their innovation goes beyond incremental improvements on existing technologies, and improves their company's ability to get safer and more efficacious products/services to market faster by reducing complexity, lowering cost, or enhancing speed and quality. Recipients will be highlighted on the Microsoft website at http://www.microsoft.com/lifesciences and on the Microsoft in Health blog at http://www.microsoft.com/health/ww/blog/Pages/index.aspx.
To learn more about the Mi-Forms best-of-breed mobile-forms software platform, visit www.mi-corporation.com and contact Mi-Co at firstname.lastname@example.org, or 919-485-4819.
Mi-Co is the developer of Mi-Forms, the market's leading Tablet e-Forms software platform. Mi-Co provides solutions for smart, flexible mobile e-Forms data collection in a variety of industries. Mi-Forms supports enterprise data capture using Windows 8 Tablets like the Microsoft Surface, the Digital Pen, iPads, Android Slates, and other mobile capture devices across diverse industries and has worked with customers like IDCRP, Lineberger Cancer Center, Eli Lilly, Sutter Health and many others. For more information on Mi-Co, please visit www.mi-corporation.com.